R-tPA Resistance Is Specific for Platelet-Rich Stroke Thrombi and Can Be Overcome by Targeting Nonfibrin Components

Post time 4 day(s) ago

Edited by Vgustavo at 2024-6-13 10:47

journal：Stroke

Authors：Sarah Vandelanotte; Olivier Francois; Linda Desender; Senna Staessens; Alexander Vanhoorne; Fréderick Van Gool; Claudia Tersteeg; Karen Vanhoorelbeke; Peter Vanacker; Tommy Andersson; Simon F. De Meyer

Published date：2024-5-

DOI：10.1161/strokeaha.123.045880

PDF link：https://www.ahajournals.org/doi/full/10.1161/STROKEAHA.123.045880

Article link：http://dx.doi.org/10.1161/strokeaha.123.045880

Article Source：Ovid Technologies (Wolters Kluwer Health)。

Remark：

Post time 4 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[AHA] R-tPA Resistance Is Specific for Platelet-Rich Stroke Thrombi and Can Be Overcome by Targeting Nonfibrin Components

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[AHA] R-tPA Resistance Is Specific for Platelet-Rich Stroke Thrombi and Can Be Overcome by Targeting Nonfibrin Components Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[AHA] R-tPA Resistance Is Specific for Platelet-Rich Stroke Thrombi and Can Be Overcome by Targeting Nonfibrin Components